Device report from japan reports an event as follows: it was reported that on (b)(4) 2022, the patient underwent orif for tibial diaphyseal fracture with the product in question and autologous bone grafting was performed on the patient's bone defects.The patient was rehabilitated with partial load, but on (b)(6) 2022, the patient fell and the plate was bent and damaged.On (b)(6) 2022, reoperation was performed to remove the plate and fix with tna.The surgeon commented that the product damage was unavoidable because of the patient's fall.No further information is available.This report is for a 3.5mm ti lcp(tm) anterolateral distal tibia pl 21 holes/left.This is report 1 of 1 for (b)(4).
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Complainant part is not expected to be returned for manufacturer review/investigation.Occupation: initial reporter is a synthes employee.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|